BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3007174)

  • 1. D-1 dopamine receptor stimulation elevates plasma prolactin levels.
    Saller CF; Salama AI
    Eur J Pharmacol; 1986 Mar; 122(1):139-42. PubMed ID: 3007174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of plasma prolactin concentrations by intravenous SCH 23390 and SKF 38393 in conscious rats.
    Tanimoto K; Tamminga CA; Chase TN
    Eur J Pharmacol; 1987 Dec; 144(2):147-51. PubMed ID: 3325296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of D1 dopamine receptors that stimulate prolactin release in the rat pituitary.
    Cocchi D; Ingrassia S; Rusconi L; Villa I; Müller EE
    Eur J Pharmacol; 1987 Oct; 142(3):425-9. PubMed ID: 2962879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D-1 receptor agonist stimulation of prolactin secretion in man.
    Fabbrini G; Braun A; Mouradian MM; Tamminga CA; Chase TN
    J Neural Transm; 1988; 71(3):159-63. PubMed ID: 2965754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo.
    Saller CF; Salama AI
    J Pharmacol Exp Ther; 1986 Mar; 236(3):714-20. PubMed ID: 3005552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D1 receptor analogues act centrally to stimulate prolactin secretion in ewes.
    Curlewis JD; Clarke IJ; McNeilly AS
    J Endocrinol; 1993 Jun; 137(3):457-64. PubMed ID: 8371076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
    Crowley WR; Parker SL; Armstrong WE; Wang W; Grosvenor CE
    Neuroendocrinology; 1991 May; 53(5):493-502. PubMed ID: 1831247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats.
    Imperato A; Mulas A; Di Chiara G
    Eur J Pharmacol; 1987 Oct; 142(1):177-81. PubMed ID: 2891544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: dissociation from effects on prolactin secretion.
    Rovescalli AC; Brunello N; Monopoli A; Ongini E; Racagni G
    Eur J Pharmacol; 1987 Mar; 135(2):129-36. PubMed ID: 3556197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.
    Breese GR; Mueller RA
    Eur J Pharmacol; 1985 Jul; 113(1):109-14. PubMed ID: 2864260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
    Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
    Brain Res; 1988 Jul; 455(2):390-3. PubMed ID: 2969768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum.
    Stoof JC; Kebabian JW
    Nature; 1981 Nov; 294(5839):366-8. PubMed ID: 6273735
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine receptor subtypes: in vivo biochemical evidence for functional interaction.
    Saller CF; Salama AI
    Eur J Pharmacol; 1985 Feb; 109(2):297-300. PubMed ID: 3873343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity.
    Borsini F; Lecci A; Mancinelli A; D'Aranno V; Meli A
    Eur J Pharmacol; 1988 Apr; 148(3):301-7. PubMed ID: 2968270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
    Carlson JH; Bergstrom DA; Weick BG; Walters JR
    Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
    Cunningham KA; Callahan PM; Appel JB
    Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.